Cargando…
Immunologically mediated regression of a murine lymphoma after treatment with anti-L3T4 antibody. A consequence of removing L3T4+ suppressor T cells from a host generating predominantly Lyt-2+ T cell- mediated immunity
This study shows that intravenous injection of 1 mg of anti-L3T4 mAb (GK1.5) into thymectomized mice bearing the syngeneic L5178Y lymphoma results, after a delay of 2-3 d, in complete regression of this tumor and in long-term host survival. A flow cytofluorometric examination of the spleen cells of...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1988
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2189164/ https://www.ncbi.nlm.nih.gov/pubmed/2974065 |
Ejemplares similares
-
Mediation of in vivo Tumor‐neutralizing Activity by Lyt‐2(+) as Well as L3T4(+) T Cell Subsets
por: Yoshioka, Takayuki, et al.
Publicado: (1988) -
Selective Suppression of the Generation of Anti‐tumor L3T4(+) but Not of Lyt‐2(+) T Cell‐mediated Immunity in the Tumor‐hearing State
por: Sano, Haruo, et al.
Publicado: (1988) -
Differential requirements for the induction of interleukin 2 responsiveness in L3T4+ and Lyt-2+ T cell subsets
Publicado: (1985) -
L3T4(CD4)-, Lyt-2(CD8)- and Mac-1(CD11b)-phenotypic leukocytes in murine cryptococcal meningoencephalitis
por: Dobrick, Peter, et al.
Publicado: (1995) -
Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. Requirement for both L3T4+ and Lyt-2+ T cells
Publicado: (1987)